COG3
Basic information
Region (hg38): 13:45464898-45536701
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Congenital disorder of glycosylation, type IIbb | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 37711075 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the COG3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 36 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 2 | 0 |
Variants in COG3
This is a list of pathogenic ClinVar variants found in the COG3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-45465041-C-T | not specified | Uncertain significance (May 26, 2022) | ||
13-45465046-G-C | not specified | Uncertain significance (Sep 26, 2023) | ||
13-45465115-C-T | not specified | Uncertain significance (Jun 10, 2024) | ||
13-45465131-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
13-45465145-G-C | Congenital disorder of glycosylation, type IIbb | Pathogenic (Oct 19, 2023) | ||
13-45465149-G-A | not specified | Uncertain significance (Mar 20, 2024) | ||
13-45465155-C-G | not specified | Uncertain significance (Mar 15, 2024) | ||
13-45465160-T-C | Congenital disorder of glycosylation, type IIbb | Pathogenic (Oct 19, 2023) | ||
13-45465167-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
13-45476207-A-G | not specified | Uncertain significance (Feb 05, 2024) | ||
13-45476249-G-A | not specified | Uncertain significance (Jul 15, 2021) | ||
13-45476270-G-A | Congenital disorder of glycosylation, type IIbb | Uncertain significance (Mar 19, 2024) | ||
13-45479026-C-A | not specified | Uncertain significance (Aug 17, 2022) | ||
13-45479039-T-C | not specified | Uncertain significance (Jun 17, 2024) | ||
13-45479059-A-G | not specified | Uncertain significance (Jan 10, 2023) | ||
13-45483294-A-G | not specified | Uncertain significance (Aug 01, 2022) | ||
13-45483329-A-T | not specified | Uncertain significance (Dec 03, 2021) | ||
13-45486497-T-A | not specified | Uncertain significance (Feb 13, 2024) | ||
13-45486556-C-G | not specified | Uncertain significance (Feb 17, 2022) | ||
13-45490945-G-A | not specified | Uncertain significance (Nov 15, 2023) | ||
13-45491449-C-G | not specified | Uncertain significance (Mar 07, 2024) | ||
13-45492234-C-T | not specified | Uncertain significance (Dec 12, 2022) | ||
13-45493454-A-G | not specified | Uncertain significance (Oct 17, 2023) | ||
13-45493474-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
13-45496269-C-T | not specified | Uncertain significance (Apr 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
COG3 | protein_coding | protein_coding | ENST00000349995 | 23 | 71706 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000705 | 125725 | 0 | 23 | 125748 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.57 | 331 | 422 | 0.785 | 0.0000204 | 5404 |
Missense in Polyphen | 86 | 130.19 | 0.66059 | 1670 | ||
Synonymous | 0.949 | 151 | 167 | 0.906 | 0.00000867 | 1537 |
Loss of Function | 5.84 | 5 | 49.2 | 0.102 | 0.00000230 | 628 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000881 | 0.0000881 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000324 | 0.000323 |
European (Non-Finnish) | 0.0000540 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000294 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in ER-Golgi transport. {ECO:0000269|PubMed:11929878}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Intra-Golgi traffic;COPI-mediated anterograde transport;ER to Golgi Anterograde Transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.82
Haploinsufficiency Scores
- pHI
- 0.258
- hipred
- Y
- hipred_score
- 0.580
- ghis
- 0.605
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.916
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cog3
- Phenotype
- vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein glycosylation;intracellular protein transport;endoplasmic reticulum to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;intra-Golgi vesicle-mediated transport;Golgi organization;protein localization to organelle;protein stabilization
- Cellular component
- Golgi membrane;Golgi apparatus;cis-Golgi network;cytosol;plasma membrane;Golgi transport complex;Golgi cisterna membrane;trans-Golgi network membrane
- Molecular function
- protein binding;protein transporter activity